Generics 4

Originals

Biosimilars

Medical devices

Nutraceuticals

Filters

Vaccine; haemophilus influenzae type b manufacturers

4 products found

Filters

4 products found

vaccine; haemophilus influenzae type b

Vials, injection Upon request

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #18252
This biotechnology company in South Asia has been operating for over two decades, focusing on developing and manufacturing vaccines and biotherapeutics. Their portfolio spans a wide range of products, including vaccines for various diseases like polio, typhoid, and rotavirus, as well as biotherapeutics for specific conditions. Key therapy areas include infectious diseases, immunology, and oncology. Their products are available in both prescription and over-the-counter forms, with dosage forms ranging from solids and liquids to injectables and orals. The company boasts manufacturing facilities that adhere to stringent EU and US GMP standards, ensuring high-quality production. The company has a strong track record in clinical research and holds several patents for its innovative products.

vaccine; haemophilus influenzae type b

Injection 0.5 ml

Dossier type
CTD
Dossier status
Ready to file
Country of origin
China
GMP approvals
China
Manufacturer #36729

Established in 1992, this CTD dossier owner and manufacturer focuses on the research, development, production, and sales of human vaccines. As a leading CTD dossier owner and manufacturer in China, the company has developed a rich product portfolio and industry-leading scale. With significant international progress, this GMP manufacturer has expanded its business development to cover six regions and more than 20 countries. The company employs over 2,400 staff and has R&D centers and industrial bases in Shenzhen and Beijing. As a GMP manufacturer, it has undertaken numerous key scientific research projects at national, provincial, and municipal levels.

vaccine; haemophilus influenzae type b

Injection 10 mcg/0.5 ml

Dossier type
CTD
Dossier status
Ready to file
Country of origin
China
GMP approvals
China
Manufacturer #36697

Established in 2002, this manufacturer employs nearly 4,500 staff and achieved an operating income of RMB 13.2 billion in the first half of 2021. As a CTD dossier owner and manufacturer, it specializes in human vaccines, with products available in 31 provinces across China. The manufacturer operates under strict GMP standards, ensuring high-quality production. With multiple production lines, it maintains its role as a CTD dossier owner and manufacturer, adhering to GMP guidelines.

 

Want to see all 4 products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription

Interested in Subscription?

Please fill out form and send us your specific requirements, and we will get back to you as soon as possible